Systemic biomarkers of oxidative stress can be relevant for assessment of psoriasis severity, for prediction of the
outcome of therapy and of the development of comorbidities. In this review we aimed to evaluate the relationship
between plasma total antioxidant capacity (TAC) and peroxidation biomarkers, as well as their association with
dyslipidemia and systemic inflammation in psoriasis. The review of 59 case–control comparisons (from 41 studies)
and 17 interventions (from 13 studies) suggests that peroxidation markers are more sensitive than TAC in the
evaluation of oxidative stress in psoriasis. Although few studies investigated the effect of treatment on oxidative
stress, it seems that biological drugs could be the better choice in the treatment of psoriasis. However, considering
the limitations of TAC and plasma peroxidation markers, this review suggests that new methods should be
developed in order to evaluate systemic oxidative stress in psoriasis